# Feeding-Triggered Seizures in a Newborn with AP1S1-Related MEDNIK Syndrome: Expanding the Phenotype of a Hyper-Rare Disease

**Authors:** Anna Cavalli, Francesca Peluso, Daniele Frattini, Carlo Alberto Cesaroni, Carolina Bondi, Giovanni Malmusi, Adelaide Peruzzi, Susanna Rizzi, Agnese Pantani, Gabriele Trimarchi, Nives Melli, Antonio Novelli, Roberta Zuntini, Giancarlo Gargano, Livia Garavelli, Carlo Fusco

PMC · DOI: 10.3390/jcm15010106 · Journal of Clinical Medicine · 2025-12-23

## TL;DR

A newborn with MEDNIK syndrome showed feeding-triggered seizures, expanding the known symptoms of this rare genetic disorder.

## Contribution

First reported case of feeding-related seizures in MEDNIK syndrome with a novel AP1S1 variant.

## Key findings

- A new AP1S1 stop variant was identified in a patient with MEDNIK syndrome.
- Feeding-related seizures were observed as an early manifestation of the disease.
- Zinc acetate therapy was trialed in managing the condition.

## Abstract

MEDNIK syndrome (Mental Retardation, Enteropathy, Deafness, Neuropathy, Ichthyosis and Keratodermia) is a severe hyper-rare condition resulting from the biallelic variants in the AP1S1 gene, implicated in intracellular trafficking and copper homeostasis. Only 18 affected individuals (seven AP1S1 pathogenic variants overall) have been reported to date, with a high early lethality due to life-threatening congenital enteropathy. Seven patients have been empirically treated with zinc. Due to the paucity of literature data, little is known about the clinical course of individuals affected by MEDNIK syndrome, and the possible early association with epilepsy needs to be investigated. We present the first case of Italian origin affected by MEDNIK syndrome carrying a new homozygous AP1S1 stop variant, presenting with congenital severe enteropathy and feeding-related seizures, thus representing an early, singular manifestation of the disease. We describe her clinical course and the zinc acetate therapeutic experience. We also reviewed the literature focusing on clinical manifestations (especially neurological), brain neuroimaging and the symptom evolution of patients with AP1S1-related MEDNIK syndrome and discuss possible future therapeutic attempts.

## Linked entities

- **Genes:** AP1S1 (adaptor related protein complex 1 subunit sigma 1) [NCBI Gene 1174]
- **Chemicals:** zinc acetate (PubChem CID 11192)
- **Diseases:** MEDNIK syndrome (MONDO:0012251), congenital enteropathy (MONDO:0013184)

## Full-text entities

- **Genes:** AP1S1 (adaptor related protein complex 1 subunit sigma 1) [NCBI Gene 1174] {aka AP19, CLAPS1, EKV3, MEDNIK, SIGMA1A}
- **Diseases:** Hyper-Rare Disease (MESH:D035583), MEDNIK Syndrome (MESH:C563739), Keratodermia (MESH:C537692), Neuropathy (MESH:D009422), Ichthyosis (MESH:D007057), epilepsy (MESH:D004827), Seizures (MESH:D012640), Enteropathy (MESH:C538273), Mental Retardation (MESH:D008607), Deafness (MESH:D003638)
- **Chemicals:** zinc acetate (MESH:D019345), copper (MESH:D003300), zinc (MESH:D015032)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12786643/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12786643/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12786643/full.md

---
Source: https://tomesphere.com/paper/PMC12786643